Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
92,601,649
-
Share change
-
+7,183,237
-
Total reported value
-
$1,651,990,072
-
Put/Call ratio
-
158%
-
Price per share
-
$17.84
-
Number of holders
-
193
-
Value change
-
+$117,644,267
-
Number of buys
-
120
-
Number of sells
-
60
Institutional Holders of Summit Therapeutics Inc. - COM (SMMT) as of Q4 2024
As of 31 Dec 2024,
Summit Therapeutics Inc. - COM (SMMT) was held by
193 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
92,601,649 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, BlackRock, Inc., FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, and Pictet Asset Management Holding SA.
This page lists
194
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.